A novel FYA allele with the 265T and 298A SNPs formerly associated exclusively with the FYB allele and weak Fyb antigen expression: implication for genotyping interpretative algorithms

Background and Objectives An Australian Caucasian blood donor consistently presented a serology profile for the Duffy blood group as Fy(a+b+) with Fya antigen expression weaker than other examples of Fy(a+b+) red cells. Molecular typing studies were performed to investigate the reason for the observ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vox sanguinis 2015-01, Vol.108 (1), p.52-57
Hauptverfasser: Lopez, G. H., Condon, J. A., Wilson, B., Martin, J. R., Liew, Y.-W., Flower, R. L., Hyland, C. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Objectives An Australian Caucasian blood donor consistently presented a serology profile for the Duffy blood group as Fy(a+b+) with Fya antigen expression weaker than other examples of Fy(a+b+) red cells. Molecular typing studies were performed to investigate the reason for the observed serology profile. Material and Methods Blood group genotyping was performed using a commercial SNP microarray platform. Sanger sequencing was performed using primer sets to amplify across exons 1 and 2 of the FY gene and using allele‐specific primers. Results The propositus was genotyped as FY*A/B, FY*X heterozygote that predicted the Fy(a+b+w) phenotype. Sequencing identified the 265T and 298A variants on the FY*A allele. This link between FY*A allele and 265T was confirmed by allele‐specific PCR. Conclusion The reduced Fya antigen reactivity is attributed to a FY*A allele‐carrying 265T and 298A variants previously defined in combination only with the FY*B allele and associated with weak Fyb antigen expression. This novel allele should be considered in genotyping interpretative algorithms for generating a predicted phenotype.
ISSN:0042-9007
1423-0410
DOI:10.1111/vox.12185